Dna Synthesis Market to grow at a CAGR of 18.1% during 2024-2028
The Dna Synthesis Market is expected to grow at a CAGR of 18.1% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 6525.3 million. The DNA synthesis market is experiencing a significant transformation through the integration of automation technology. Automated systems are now capable of synthesizing DNA sequences with high precision and efficiency, minimizing human intervention. One notable advancement is the development of in-house DNA synthesis using automated benchtop systems. These systems enable rapid construction, cloning, and amplification of new genetic candidates within a few days, reducing traditional time and labor requirements. This automation not only accelerates research but also safeguards proprietary vector information throughout the discovery process, making it a game-changer in the genetic engineering industry.
Get more information on Dna Synthesis Market by requesting a sample report
Technavio analysts predict that the Oligonucleotide synthesis subsegment will lead the Type segment during 2024 and 2028 In the realm of biotechnology, oligonucleotides, or oligos, represent short sequences of nucleic acids, which can be single or double-stranded. These sequences are synthesized by linking together nucleotides, the building blocks of DNA and RNA, to form single-chain biological polymers. Each nucleotide comprises a nitrogenous base, a five-carbon sugar molecule, and one or more phosphate groups. Furthermore, nucleotides can incorporate non-natural or non-canonical bases, such as Locked Nucleic Acids (LNA), Morpholino, and other structurally modified bases or backbones. The production of oligonucleotides is primarily achieved through chemical DNA synthesis, utilizing advanced phosphoramidite technology. This method sets the industry standard for oligonucleotide manufacturing, ensuring high-quality and precise sequences for various applications.
Here are the various ways based on which the market is segmented:
There are several factors that are causing the market to flourish increasing use of dna synthesis-based therapeutics
Learn which are the obstacles that the market is experiencing in the way of its growth by accessing the free PDF report
The DNA synthesis market is experiencing significant growth due to its applications in various fields, including ovarian cancer research, disease diagnostics, forensic investigation, medical research, and synthetic biology. Deoxyribonucleic acid (DNA) synthesis plays a crucial role in genetic disease diagnostics, enabling the identification of genetic variations linked to diseases such as ovarian cancer. In addition, DNA synthesis is used in the production of RNA molecules for therapeutic candidates, gene editing, and gene therapy. The Precision Medicine Initiative and genome editing are driving the demand for custom gene synthesis and targeted therapies. Oligonucleotide synthesis is also essential in molecular diagnostics, vaccines, drug development, and gene therapies. Synthetic techniques for DNA synthesis have advanced significantly, leading to the production of tailored therapies and therapeutic candidates for various diseases. Furthermore, DNA synthesis is used in the study of cancer genomics and pathogens, making it an essential tool in medical research and clinical diagnostics. Overall, the DNA synthesis market is expected to continue growing due to its applications in various fields, including personalized treatment, synthetic biology, and therapeutic development.
The global life sciences tools and services market encompasses businesses involved in the research and development (R&D) of a range of product categories, including capital equipment, instruments, accessories, and consumables. These tools are utilized in the production of pharmaceuticals, biotechnology products, and laboratory diagnosis of various diseases. Additionally, this market includes life sciences-related services such as contract research, manufacturing, and sales. According to Technavio, the healthcare market size is determined by the consolidated revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life science tools and services. The expansion of the global life science tools and services market will be fueled by several key factors, including the increasing elderly population, growing demand for personalized medicine, and advancements in genomics and proteomics technologies.
The Dna Synthesis Market is experiencing significant growth, fueled by the increasing use of dna synthesis-based therapeutics. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
